Trump touts expanded use of convalescent plasma for COVID-19 patients; the US military has already been using it – NavyTimes.com

While President Trump announced Sunday an emergency authorization for the use of convalescent plasma to treat hospitalized COVID-19 patients, such plasma is already being administered to infected U.S. servicemembers.

Trump heralded the recent policy change as a breakthrough, but the benefit of COVID convalescent plasma, or CCP, in treating those infected with the novel coronavirus remains unknown.

In the treatment, plasma is collected from people who have recovered from a COVID-19 infection and whose blood therefore contains antibodies. In theory, these antibodies could help neutralize the virus and improve the outlook for patients who are newly fighting the disease. But the medical community has not determined whether injecting CCP into sickened patients kick-starts the immune system and aids in recovery.

Even so, a U.S. Food and Drug Administration statement accompanying the presidents announcement notes that the potential benefits of the product outweigh the known and potential risks of the product. The plasma can also complement other treatments, rather than replace them.

Under a program started in May by the U.S. Armys Medical Materiel Development Activity, with FDA approval, 14 people have been treated with CCP, officials said.

Theyve received the plasma and are being followed over the disease course to see how quickly they recover, Army Lt. Col. Sandi Parriott, director of the activitys Force Health Protection division, told Military Times last week.

Data on the outcomes of such plasma treatments is then sent to the FDA, she said.

Don't miss the top Navy stories, delivered each afternoon

(please select a country) United States United Kingdom Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic of The Cook Islands Costa Rica Cote D'ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe

Subscribe

By giving us your email, you are opting in to the Navy Times Daily News Roundup.

Of those 14 CCP recipients, half were treated downrange, according to Carey Phillips, a spokeswoman for the Army medical activity.

Two of the 14 were active-duty servicemembers. Four dependents, two contractors, one Defense Department civilian and two retirees also received CCP, Phillips said in an email.

Three foreign nationals, who received special permission, also received the plasma, Phillips said.

Twelve of the 14 were older than 50 and every recipient was dealing with severe to life-threatening disease, according to Phillips.

CCP harvested from recovered military volunteers has been placed at nearly 30 locations worldwide, including military bases and aboard Navy ships.

While it remains to be seen whether convalescent plasma is an effective treatment for those sickened by COVID-19, theres very little risk in using it, Parriott said.

Youre giving antibodies from someone who has fought off the disease, she said. You think that would help, and help the body mount a better immune response against the virus, but we dont know for sure.

The U.S. Defense Department hopes to obtain 10,000 units of COVID convalescent plasma by the end of September. The trials are ongoing and Parriott suspects that final determinations regarding the therapys efficacy should be known in the next six months or so.

As of Monday, there have been 36,232 COVID-19 cases in the uniformed ranks, according to the Pentagon.

The Armys Landstuhl Regional Medical Center, Germany the largest American hospital outside the United States and the treatment and evacuation hub for wounded troops coming from Iraq and Afghanistan was the first of 27 sites approved for the CCP protocol. Others include Madigan Army Medical Center, Washington; Yokota Air Base Medical Treatment Facility in Japan; U.S. Naval Hospital Guam; and the Evans Army Community Hospital in Colorado. The plasma is also available at at Bagram Airfield, Afghanistan, and the military medical center in Baghdad.

A lot of our population is outside (the continental United States), Parriott said. We have to get a little more creative on how we prevent and how we make these treatment options available.

Several Navy ships now serve as CCP sites as well, with the aircraft carrier Nimitz becoming the first to be approved last month.

Other ships capable of administering the convalescent plasma to COVID-19 patients include the carriers Abraham Lincoln, Ronald Reagan, Dwight D. Eisenhower and Gerald R. Ford, as well as the amphibious assault ship America, according to an Army release on the program.

To be eligible for the CCP program, sites must be capable of treating severe or life-threatening COVID cases and they must volunteer by reaching out the medical activity for consideration, Phillips said.

While the efficacy of convalescent plasma in COVID patients remains unknown, plasma has been used in the past to successfully treat other respiratory viruses, noted Navy Capt. Gilbert Seda, head of the Nimitzs COVID-19 response team, in the Army release.

In order to qualify for CCP treatment, patients must have a laboratory-confirmed COVID-19 infection, have provided informed consent, have severe or life-threatening COVID-19 illness and not have any medical contraindications to receiving the plasma, Dr. Seda said.

To be clear, the CCP treatment protocol does not change the Navys plan to get Sailors with severe COVID-19 illness off the ship as soon as possible, Seda said.

If you have contracted and recovered from COVID-19, go here to learn more about donating your plasma.

Army Maj. Gen. Michael Place contracted COVID-19 in March and has now donated plasma several times, according to an Army release.

This is Soldiers and Soldiers Families taking care of Soldiers, said Place, the commanding officer of the Armys 18th Medical Command in Hawaii. You sit in this comfortable chair for a little while, they take the plasma from you and give you some cookies and snacks and some departure gifts.

Read the original post:

Trump touts expanded use of convalescent plasma for COVID-19 patients; the US military has already been using it - NavyTimes.com